前列腺PET/CT与mpMRI及组织学体素级配准相关性研究
本研究开发了一种配准框架,将前列腺PET/CT与mpMRI及组织学进行体素级关联。九例拟行根治性前列腺切除术患者术前接受mpMRI和PET/CT,所有数据成功配准;良性与肿瘤体素的PET SUV分布均存在统计学差异,DCE-MRI灌注参数和BOLD氧合参数与PET SUV呈一致相关。
要点
- 成功实现前列腺PET/CT与mpMRI及组织学的体素级配准。
- 所有患者良性与肿瘤体素的PET SUV分布存在统计学差异。
- DCE-MRI灌注参数和BOLD参数与PET SUV呈一致相关。
核心结论
- 成功开发了将PET/CT数据与mpMRI及组织学在体素水平配准和关联的新框架。
- 尽管存在配准不确定性,DCE-MRI灌注参数和BOLD成像氧合参数与PET SUV显示相关性。
研究设计与样本
- 前瞻性概念验证研究,纳入九例计划行根治性前列腺切除术的患者。
- 术前进行mpMRI和PET/CT成像,PET示踪剂包括18F-氟甲基胆碱、68Ga-PSMA-HBED-CC和试验性68Ga-THP-PSMA。
- PET/CT通过CT扫描和体内三维T2加权MRI与mpMRI配准,再通过离体前列腺标本MRI与组织学数据配准。
主要发现
- 所有九例患者的PET/CT数据均成功与mpMRI和组织学数据配准。
- SUVmax范围为2.21至12.11,SUVmean范围为1.08至4.21。
- 所有患者良性与肿瘤体素的PET SUV值分布存在统计学差异。
- T2w或ADC值与PET SUV无一致相关性。
- DCE-MRI参数(最大强化、Ktrans、iAUGC60)与PET SUV呈一致正相关;BOLD MRI的R2*值与PET SUV体素值呈一致负相关。
关键数值与推荐
- 使用组织学肿瘤标注提取PET数据的SUVmax和SUVmean,采用Kolmogorov-Smirnov检验比较肿瘤与良性体素值。
- 采用Pearson相关系数和R2统计量分析mpMRI与PET SUV肿瘤体素值的相关性。
临床怎么用
- 该配准框架可为前列腺局灶治疗规划提供mpMRI与PET相关性的支持信息。
- 需在更大患者队列中进一步分析以量化这些概念验证发现。
局限性
- 存在配准不确定性。
- 样本量小(九例),为概念验证研究,需更大队列进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop a registration framework for correlating positron emission tomography/computed tomography (PET/CT) images with multiparametric magnetic resonance imaging (mpMRI) and histology of the prostate, thereby enabling voxel-wise analysis of imaging parameters. PATIENTS AND METHODS: In this prospective proof-of-concept study, nine patients scheduled for radical prostatectomy underwent mpMRI and PET/CT imaging before surgery. One had PET imaging using 18 F-fluoromethylcholine, five using 68 Ga-labelled prostate-specific membrane antigen (PSMA)-HBED-CC (PMSA-11), and three using a trial 68 Ga-labelled THP-PSMA tracer. PET/CT data were co-registered with mpMRI via the CT scan and an in vivo three-dimensional T2-weighted (T2w) MRI, and then co-registered with ground truth histology data using ex vivo MRI of the prostate specimen. Maximum and mean standardised uptake values (SUVmax and SUVmean ) were extracted from PET data using tumour annotations from histology, and Kolmogorov-Smirnov tests were used to compare between tumour- and benign-voxel values. Correlation analysis was performed between mpMRI and PET SUV tumour voxel values using Pearson's correlation coefficient and R2 statistics. RESULTS: PET/CT data from all nine patients were successfully registered with mpMRI and histology data. SUVmax and SUVmean ranged from 2.21 to 12.11 and 1.08 to 4.21, respectively. All patients showed the PET SUV values in benign and tumour voxels were from statistically different distributions. Correlation analysis showed no consistent trend between the T2w or apparent diffusion coefficient values and PET SUV. However, parameters from dynamic contrast-enhanced (DCE) MRI including the maximum enhancement, volume transfer constant (Ktrans ), and the initial area under the contrast agent concentration curve for the first 60 s after injection (iAUGC60), showed consistent positive correlations with PET SUV. Furthermore, R2* values from blood oxygen level-dependent (BOLD) MRI showed consistent negative correlations with PET SUV-voxel values. CONCLUSION: We have developed a novel framework for registering and correlating PET/CT data at a voxel-level with mpMRI and histology. Despite registration uncertainties, perfusion and oxygenation parameters from DCE MRI and BOLD imaging showed correlations with PET SUV. Further analysis will be performed on a larger patient cohort to quantify these proof-of-concept findings. Improved understanding of the correlation between mpMRI and PET will provide supportive information for focal therapy planning of the prostate.
引用
- Reynolds HM, Williams S, Jackson P, et al. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework. BJU Int. 2019. PMID: 30536698. doi:10.1111/bju.14648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。